Skip to main content

Table 2 Baseline clinical characteristics of TB-HIV co- infected patients in Bahir Dar town, 2012

From: Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study

Base line variable On ART (n = 272) Non-ART (n = 150) X 2Value (df) P- Value
Past OIs (n = 366)     
   Yes 105 (43.6%) 55 (44.0%) 0.006 0.937
   No 136 (56.4%) 70 (56.0%) (1)  
Past TB Treatment (n = 402)     
   Yes 58 (22.4%) 31 (21.7%) 0.027 0.869
   No 201 (77.6%) 112 (78.3%) (1)  
Functional status (n = 397)     
   Working 159 (60.9%) 80 (58.8%) 1.363 0.506
   Ambulatory 72 (27.6%) 44 (32.4%) (2)  
   Bedridden 30 (11.5%) 12 (8.8%)   
CD4 count (n = 408)     
   Mean ± SD 132.9 ± 94.42 312.78 ± 192.8 10.30♦ 0.000*
   Median (IQR) 114 (58-185) 291 (183.5-448)   
Hgb level (mmHg)(n = 357)     
   Mean ± SD 11.36 ± 2.3 11.46 ± 1.83 0.063♦ 0.95
   Median (IQR) 11.3 (10.0-13.0) 12.0 (10.12-13.0)   
TB diagnosis     
   Smear Positive PTB 53 (19.5%) 40 (26.7%) 10.434 0.005*
   Smear Negative PTB 107 (39.3%) 36 (24.0%) (2)  
   Extra PTB 112 (41.2%) 74 (49.3%)   
CPT (n = 397)     
   Prescribed 239 (93.0%) 109 (77.9%) 19.19 0.000*
   Not Prescribed 18 (7.0%) 31 (22.1%) (1)  
Outcome of TB Treatment (n = 417)     
   Cure 37 (13.7%) 16 (11.0%) 8.039 0.045*
   Treatment completed 167 (61.6%) 77 (52.7%) (3)  
   Defaulter 18 (6.6%) 9 (6.2%)   
   Death 49 (18.1%) 44 (30.1%)   
  1. * Significant at α = 0.05, ♦ = T-test Statistic for independent sample test used.